Antibacterial activity of sucralfate versus aluminum chloride in simulated gastric fluid
- PMID: 7889966
- DOI: 10.1007/BF02111825
Antibacterial activity of sucralfate versus aluminum chloride in simulated gastric fluid
Abstract
Studies have previously demonstrated that sucralfate possesses intrinsic antibacterial activity. This study was designed to indirectly assess whether aluminum is the active antibacterial component of sucralfate and to further evaluate factors that may influence this agent's antibacterial activity. Utilizing an in vitro model, the antibacterial activity of sucralfate, an equivalent quantity of aluminum in the form of aluminum chloride, and a control were compared. In addition, the influences of bacterial species (Enterobacter cloacae and Pseudomonas aeruginosa), time (0-24 h) and environmental pH (3,5,7) on the agents' antibacterial activities were evaluated. Equivalent quantities of aluminum, as either sucralfate or aluminum chloride, were added to two of three flasks containing approximately 10(5) cfu/ml of bacteria in pH-adjusted simulated gastric fluid. The third flask served as a control. Samples were obtained over 24 h, diluted and subcultured onto agar plates. The experiments demonstrated that bacterial growth was influenced by pH, time and treatment (aluminum chloride or sucralfate). Regardless of pH or bacterial species, bacterial death occurred within 20 min following the addition of aluminum chloride. In contrast, bacterial death following the addition of sucralfate was more variable and appeared to be pH dependent. In conclusion, sucralfate and aluminum chloride both possess antibacterial activity, even at pH values that normally support bacterial growth in gastric fluid. Although differences in the antibacterial activity of the two agents may in part be related to drug-induced changes in pH, these differences also support data suggesting that aluminum release from sucralfate is incomplete and is dependent on pH.
Similar articles
-
Antibacterial activity of sucralfate in human gastric juice.Am J Med. 1987 Sep 28;83(3B):125-7. doi: 10.1016/0002-9343(87)90841-2. Am J Med. 1987. PMID: 3310627
-
In vitro antibacterial activity of sucralfate.Eur J Clin Microbiol Infect Dis. 1994 Jul;13(7):615-20. doi: 10.1007/BF01971318. Eur J Clin Microbiol Infect Dis. 1994. PMID: 7805695
-
Antacid, sucralfate, and prostaglandin E2 effects on the growth and potential for translocation of Pseudomonas aeruginosa, Escherichia coli, and Staphylococcus aureus in an in vitro gastric simulation.J Burn Care Rehabil. 1991 Jan-Feb;12(1):7-12. doi: 10.1097/00004630-199101000-00003. J Burn Care Rehabil. 1991. PMID: 1902478
-
[Sucralfate: development of a new concept of anti-ulcer treatment. Review of its pharmacodynamic properties].Rev Med Interne. 1985 Jun;6(3):313-9. doi: 10.1016/s0248-8663(85)80124-7. Rev Med Interne. 1985. PMID: 3901171 Review. French.
-
[The use of aluminum and its compounds for the biomedical purposes].Fiziol Zh (1994). 2014;60(1):91-7. Fiziol Zh (1994). 2014. PMID: 24809180 Review. Ukrainian.
Cited by
-
Efficacy and safety of stress ulcer prophylaxis in critically ill patients: a network meta-analysis of randomized trials.Intensive Care Med. 2018 Jan;44(1):1-11. doi: 10.1007/s00134-017-5005-8. Epub 2017 Dec 4. Intensive Care Med. 2018. PMID: 29199388 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical